Abstract
Malaria recurrences after an initially successful therapy and malarial fever occurring a long time after infection are well-known problems in malariology. Currently, two distinct types of malaria recurrences are defined: recrudescence and relapse. A recrudescence is thought to originate from circulating Plasmodium blood stages which do not cause fever before a certain level of a microscopically detectable parasitemia is reached. Contrary, a relapse is thought to originate from quiescent intracellular hepatic parasite stages called hypnozoites. Recrudescences would typically occur in infections due to Plasmodium falciparum. Plasmodium knowlesi, and Plasmodium malariae, whereas relapses would be caused exclusively by Plasmodium vivax and Plasmodium ovale. This schematic view is, however, insufficiently supported by experimental evidence. For instance, hypnozoites of P. ovale have never been experimentally documented. On the other hand, the nonfinding of P. malariae hypnozoites turned into the proof for the nonexistence of P. malariae hypnozoites. Clinical relapse-type recurrences have been observed in both P. ovale and P. malariae infections, and decade-long incubation times have also been reported in P. falciparum infections. We propose a gradual hypothesis in accordance with the continuity concept of biological evolution: both, relapse and recrudescence may be potentially caused by all Plasmodium spp. We hypothesize that the difference between the various Plasmodium spp. is quantitative rather than qualitative: there are Plasmodium spp. which frequently cause relapses such as P. vivax, particularly the P.v. Chesson strain, species which cause relapses less frequently, such as P. ovale and sometimes P. malariae, and species which may exceptionally cause relapses such as P. falciparum. All species may cause recrudescences. As clinical consequences, we propose that 8-aminquinolines may be considered in a relapse-type recrudescence regardless of the causal Plasmodium sp., whereas primaquine relapse prevention might not be routinely indicated in malaria due to P. ovale.
Similar content being viewed by others
References
Abdelkefi A, Ben Othman T, Torjman L, Ladeb S, Lakhal A, Belhadj S, Ayari S, Cherif N, Ben Achour O, Chaker E, Ben Abdeladhim A (2004) Plasmodium falciparum causing hemophagocytic syndrome after allogeneic blood stem cell transplantation. B Hematol J 5:449–450
Aguilar R, Magallon-Tejada A, Achtman AH, Moraleda C, Joice R, Cisteró P, Li Wai Suen CS, Nhabomba A, Macete E, Mueller I, Marti M, Alonso PL, Menéndez C, Schofield L, Mayor A (2014) Molecular evidence for the localization of Plasmodium falciparum immature gametocytes in bone marrow. Blood 123:959–966
Arends JE, Oosterheert JJ, Kraaij-Dirkzwager MM, Kaan JA, Fanoy EB, Haas PJ, Scholte EJ, Kortbeek LM, Sankatsing SU (2013) Two cases of Plasmodium falciparum malaria in the Netherlands without recent travel to a malaria-endemic country. Am J Trop Med Hyg 89:527–530
Berrevoets MA, Sprong T, Meis JF, Dofferhoff AS (2013) Plasmodium falciparum malaria recrudescence occurring 2.5 years after leaving an endemic country. Neth J Med 71:426–428
Besson P, Robert JF, Reviron J, Richard-Lenoble D, Gentilini M (1976) A propos de deux observations du paludisme transfusionnel: essai de prevention associant un test d’immunofluorescence indirecte aux critères de selection clinique. Rev Fr Transfus Immunohematol 19:369–373
Bidegain F, Berry A, Alvarez M, Verhille O, Huguet F, Brousset P, Pris J, Marchou B, Magnaval JF (2005) Acute Plasmodium falciparum malaria following splenectomy for suspected lymphoma in 2 patients. Clin Infect Dis 40:e97–e100
Bottieau E, Clerinx J, Van den Enden E, Van Esbroeck M, Colebunders R, Van Gompel A, Van Den Ende J (2000) Imported non-Plasmodium falciparum malaria: a five-year prospective study in a European referral center. Am J Trop Med Hyg 75:133–138
Bottieau E, Gompel A, Peetermans WE (2005) Failure of primaquine therapy for the treatment of Plasmodium ovale malaria. Clin Infect Dis 41(10):1544–1545
Bradie M (1994) Epistemology from an evolutionary point of view. In: Sober E (ed) Conceptual issues in evolutionary biology, 2nd edn. Mass MIT Press, Cambridge, pp 453–475
Bruce-Chwatt LJ (1972) Blood transfusion and tropical disease. Trop Dis Bull 69:825–862
Carter R, Mendis KN (2002) Evolutionary and historical aspects of the burden of malaria. Clin Microbiol Rev 15:564–594
Chadee DD, Tilluckdharry CC, Maharaj P, Sinanan C (2000) Reactivation of Plasmodium malariae infection in a Trinidadian man after neurosurgery. N Engl J Med 342:1924
Chin W, Coatney GR (1971) Relapse activity of sporozoite-induced infections with a West-African strain of Plasmodium ovale. Am J Trop Med Hyg 20:825–827
Ciuca M, Lupasco GH, Negulici E, Constantinesco P (1964) Recherches sur la transmission expérimentale de P. malariae à l’homme. Arch Roumains Path Exp Microbiol 23:763–776
Coatney GR (1976) Relapse in malaria--an enigma. J Parasitol 62(1):3–9
Cogswell FB, Krotoski WA, Hollingdale MR, Gwadz RW (1983) Identification of hypnozoites and tissue schizonts of Plasmodium vivax and Plasmodium cynomolgi by the immunoperoxidase method. Am J Trop Med Hyg 32:1454–1455
Cogswell FB, Collins WE, Krotoski WA, Lowrie RC (1991) Hypnozoites of Plasmodium simiovale. Am J Trop Med Hyg 45:211–213
Coldren R, Jongsakul K, Vayakornvichit S, Noedl H, Fukuda MM (2007) Apparent relapse of imported Plasmodium ovale malaria in a pregnant woman. Am J Trop Med Hyg 77(5):992–994
Collins WE, Jeffery GM (1999) A retrospective examination of the patterns of recrudescence in patients infected with Plasmodium falciparum. Am J Trop Med Hyg 61(1 Suppl):44–48
Collins WE, Jeffery GM (2007) Plasmodium malariae: parasite and disease. Clin Microbiol Rev 20:579–592
Collins WE, Sullivan JS, Jeffery GM, Williams A, Galland GG, Nace D, Williams T, Barnwell JW (2009) The Chesson strain of Plasmodium vivax in humans and different species of Aotus monkeys. Am J Trop Med Hyg 80:152–159
Cuartas F, Rothenberg J, Fecci C, Gutterman J (1972) Diagnosis of malaria by bone marrow aspiration. South Med J 65:523
Del Punta V, Gulletta M, Matteelli A, Spinoni V, Regazzoli A, Castelli F (2010) Congenital Plasmodium vivax malaria mimicking neonatal sepsis: a case report. Malar J 9:63. doi:10.1186/1475-2875-9-63
Diaz Hernández A, Péres Avila J, Millán Marcelo JC (1984) Recaídas tardías en paludismo por Plasmodium ovale (Stephens, 1922). Rev Cubana Med Trop 36(1):11–18
Dixit MB (1958) Unusual length of a Plasmodium ovale infection. BMJ 27:1578
Do Rosário VE, Couto AA, Santos MA, de Souza JM (1985) Characterization of P. falciparum strains obtained from relapsed patients. Rev Inst Med Trop S Paulo 27:274–278
Eloy O, Zuily E, Greder-Belan A, Bouchot C, Ghnassia JC, Legros F (1998) Plasmodium falciparum malaria. 4 years after returning from an endemic zone]. Presse Med 27:1898
Escalante AA, Freeland DE, Collins WE et al (1998) The evolution of primate malaria based on the gene encoding cytochrome b from the linear mitochondial genome. Proc Natl Acad Sci U S A 95:8124–8129
Fernando D, Rodrigo C, Rajapakse S (2011) Primaquine in vivax malaria: an update and review on management issues. Malar J 10:351. doi:10.1186/1475-2875-10-351
Focà E, Zulli R, Buelli F, de Vecchi M, Regazzoli A, Castelli F (2009) Plasmodium falciparum malaria recrudescence in a cancer patient. Le Infezioni Med I 17:33–34
Forestier E, Labe A, Raffenot D, Lecomte C, Rogeaux O (2011) Post-malaria neurological syndrome complicating a relapse of Plasmodium falciparum malaria after atovaquone-proguanil treatment. Med Mal Infect 41:41–43
Franken G, Müller-Stöver I, Holtfreter MC, Walter S, Mehlhorn H, Labisch A, Häussinger D, Richter J (2012) Why do Plasmodium malariae infections sometimes occur in spite of previous antimalarial medication? Parasitol Res 111:943–946
Galappaththy GN, Tharyan P, Kirubakaran R (2013) Primaquine for preventing relapse in people with Plasmodium vivax malaria treated with chloroquine. Cochrane Database Syst Rev 10:CD004389. doi:10.1002/14651858.CD004389.pub3
Gallien S, Taieb F, Schlemmer F et al (2008) Failure of atovaquone/proguanil to prevent Plasmodium ovale malaria in a traveler returning from Cameroon. Travel Med Infect Dis 6:128–129
Garavelli PL (1988) [Recurrent malaria caused by Plasmodium falciparum after therapy with quinine]. Recenti Prog Med 89: 406 [Article in Italian]
Garnham PCC (1981) The myth of quartan malaria. Trans Roy Soc Trop Med Hyg 75:616–617
Garnham PCC (1988) Swellengrebel Lecture: hypnozoites and ‘relapses’ in Plasmodium vivax and in vivax-like malaria. Trop Geogr Med 40:187–195
Garnham PCC, Bray RS, Bruce-Chwatt LJ, Draper CC, Killick-Kendrick R, Sergiev PG, Tiburskaja NA, Shute PG, Maryon M (1975) A strain of Plasmodium vivax characterized by prolonged incubation: morphological and biological characteristics. Bull Wld Hlth Organ 52:21–32
Giacomini T, Baledent F, Hanania G (1988) Transfusion malaria caused by Plasmodium ovale. A case. Presse Med 17:755–756
Gibson JJ, Brodsky RE, Schultz M (1974) Changing pattern of malaria in the United States. J Infect Dis 130:553–555
Giobbia M, Tonon E, Zanatta A, Cesaris L, Vaglia A, Bisoffi Z (2005) Late recrudescence of Plasmodium falciparum malaria in a pregnant woman: a case report. Int J Infect Dis 9:234–235
Greenwood T, Vikerfors T, Sjöberg M, Skeppner G, Färnert A (2008) Febrile Plasmodium falciparum malaria 4 years after exposure in a man with sickle cell disease. Clin Infect Dis 47:e39–e41
Grobusch MP, Göbels K, Teichmann D (2004) Is quartan malaria safley prevented be mefloquine prophylaxis? J Travel Med 11:125–126
Gueirard P, Tavares J, Thiberge S, Bernex F, Ishino T, Milon G, Franke-Fayard B, Janse CJ, Ménard R, Amino R (2010) Development of the malaria parasite in the skin of the mammalian host. Proc Natl Acad Sci U S A 107(43):18640–18645. doi:10.1073/pnas.1009346107, Epub 2010 Oct 4
Harwin RM (1971) Malaria due to Plasmodium ovale in Rhodesia. Centr Afr J Med 17:146–148
Hase R, Uwamino Y, Muranaka K, Tochitani K, Sogi M, Kitazono H, Hosokawa N (2013) Plasmodium malariae malaria with more than a 4-month incubation period: difficult to distinguish from a relapse of Plasmodium vivax malaria. Kansenshogaku Zasshi 87:446–450
Herzog C, Ellis CJ, Innes JA, Fletcher KA (1988) Possible role of drug malabsorption in recrudescence of falciparum malaria. Presse Med 27:1577–1578
Hess FJ, Kilian AD, Nothdurft HD, Löscher T (1993) Problems in the therapy of mixed malarial infection: a case of infection with Plasmodium falciparum and P. malariae treated with mefloquine and halofantrine. Trans R Soc Trop Med Hyg 87:688
Higgins JM (2015) Red blood cell population dynamics. Clin Lab Med 35:43–57
Hong YJ, Yang SY, Lee K, Kim TS, Kim HB, Park KU, Song J, Kim EC (2012) A case of imported Plasmodium malariae malaria. Ann Lab Med 32:229–233
Hung CC, Chang SC, Chen YC, Yen TS, Hsieh WC (1994) Plasmodium vivax infection in a renal transplant recipient: report of a case. J Formos Med Assoc 93:888–889
Jiménez BC, Navarro M, Huerga H et al (2006) Tertian malaria (Plasmodium vivax and Plasmodium ovale) in two travelers despite atovaquone-proguanil prophylaxis. J Travel Med 13:373–375
Joice R, Nilsson SK, Montgomery J, Dankwa S, Egan E, Morahan B, Seydel KB, Bertuccini L, Alano P, Williamson KC, Duraisingh MT, Taylor TE, Milner DA, Marti M (2014) Plasmodium falciparum transmission stages accumulate in the human bone marrow. Sci Transl Med 6(244):244re5. doi:10.1126/scitranslmed.3008882
Kang Y, Yang J (2013) A case of Plasmodium ovale malaria imported from West Africa. Korean J Parasitol 51(2):213–218
Karmodiya K, Pradhan SJ, Joshi B, Jangid R, Reddy PC, Galande S (2015) A comprehensive epigenome map of Plasmodium falciparum reveals unique mechanisms of transcriptional regulation and identifies H3K36me2 as a global mark of gene suppression. Epigenetics Chromatin 8:32, eCollection 2015
Kaur K, Jain M, Reddy RP, Jain R (2010) Quinolines and structurally related heterocycles as antimalarials. Eur J Med Chem 45:3245–3264
Kroll MH, Bienzle U, Burger W, Weber B (1984) Chloroquine and pyrimethamine/sulfadoxine resistant malaria tropica in a child with diabetes mellitus. Monatsschr Kinderheilkd 132:301–302
Krotoski WA (1985) Discovery of the hypnozoite and a new theory of malaria relapse. Trans Roy Soc Trop Med Hyg 79:1–11
Krotoski WA, Collins WE (1982) Failure to detect hypnozoites in hepatic tissue containing exoerythrocytic schizonts of Plasmodium knowlesi. Am J Trop Med Hyg 3:854–856
Krotoski WA, Krotoski DM, Garnham PC, Bray RS, Killick-Kendrick R, Draper CC, Targett GA, Guy MW (1980) Relapses in primate malaria: discovery of two populations of exoerythrocytic stages. Preliminary note BMJ 280:153–154
Krotoski WA, Bray RS, Garnham PC, Gwadz RW, Killick-Kendrick R, Draper CC, Targett GA, Krotoski DM, Guy MW, Koontz LC, Cogswell FB (1982) Observations on early and late post-sporozoite tissue stages in primate malaria. II. The hypnozoite of Plasmodium cynomolgi bastianellii from 3 to105 days after infection, and detection of 36- to 40- hour pre-erythrocytic forms. Am J Trop Med Hyg 31:211–225
Krotoski WA, Garnham PC, Cogswell FB, Collins WE, Bray RS, Gwasz RW, Killick-Kendrick R, Wolf RH, Sinden R, Hollingdale M, Lowrie RC Jr, Koontz LC, Stanfill PS (1986) Observations on early and late post-sporozoite tissue stages in primate malaria. IV. Pre-erythrocytic schizonts and/or hypnozoites of Chesson and North Korean strains of Plasmodium vivax in the chimpanzee. Am J Trop Med Hyg 35:263–274
Krüger A, Rech A, Su XZ, Tannich E (2001) Two cases of autochthonous Plasmodium falciparum malaria in Germany with evidence for local transmission by indigenous Anopheles plumbeus. Trop Med Int Health 6:983–985
Kugasia,IR, Polara FK, Assallum H (2014) Recrudescence of Plasmodium malariae after Quinine. Case Reports in Medicine 2014, Article ID 590265
Kuyucu N, Yarali N, Sönmezişik G, Yilmaz S, Teziç T (1999) Congenital malaria: a case report. Turk J Pediatr 41:103–106
Kyle, DE, Webster, HK (1996) Postantibiotic effect of quinine and dihydroartemisinin derivatives on Plasmodium falciparum in vitro: implications for a mechanism of recrudescence. Abstracts of the XIVth International Congress for Tropical Medicine and Malaria; 1996. Abstract 0-22-6
Kyrönseppä H, Tiula E, Repo H, Lähdevirta J (1989) Diagnosis of falciparum malaria delayed by long incubation period and misleading presenting symptoms: life-saving role of manual leucocyte differential count. Scand J Infect Dis 21:117–118
Landau I, Chabaud AG, Mora-Silvera E, Coquelin F, Boulard Y, Rénia L, Snounou G (1999) Survival of rodent malaria merozoites in the lymphatic network: potential role in chronicity of the infection. Parasite 6:311–322
Laochan N, Zaloumis SG, Imwong M, Lek-Uthai U, Brockman A, Sriprawat K, Wiladphaingern J, White NJ, Nosten F, McGready R (2015) Intervals to Plasmodium falciparum recurrence after anti-malarial treatment in pregnancy: a longitudinal prospective cohort. Malar J 14:221
Lau YL, Tan LH, Chin LC, Fong MY, Noraishah MA, Rohela M (2011) Plasmodium knowlesi reinfection in a human. Emerg Infect Dis 17:1314–1315
Lau YL, Lee WC, Tan LH, Kamarulzaman A, Syed Omar SF, Fong MY, Cheong FW, Mahmud R (2013) Acute respiratory distress syndrome and acute renal failure from Plasmodium ovale infection with fatal outcome. Malar J 12:389
Le Marty P, Chapdelaine B, Fichoux Y, Chabert JM (1987) Paludisme anémant à Plasmodium ovale après 45 mois d’incubation. Nouv Presse Med 16:357
Li Y, Wang G, Sun D, Meng F, Lin S, Hu X, Wang S (2013) A case of Plasmodium ovale wallikeri infection in a Chinese worker returning from West Africa. Korean J Parasitol 51:557–562
Mair GR, Braks JA, Garver LS, Wiegant JC, Hall N, Dirks RW, Khan SM, Dimopoulos G, Janse CJ, Waters AP (2006) Regulation of sexual development of Plasmodium by translational repression. Science 313(5787):667–669
Markus MB (2010) The hypnozoite concept with particular reference to malaria (2010). Parasitol Res 108:247–252
Markus MB (2011) Malaria; origin of the term “hypnozoite” J. Hist Biol 44:781–786
Markus MB (2012) Dormancy in mammalian malaria. Trends Parasitol 28:39–45
Markus MB (2015) Do hypnozoites cause relapse in malaria? Trends Parasitol 1359:1–7
Martini E (1951) Lehrbuch der medizinischen Entomologie, 4th edn. Gustav Fischer Verlag Jena, Germany; pp 426–432 [German]
Mazier D, Collins WE, Mellouk S, Procell PM, Berbiguier N, Campbell GH, Miltgen F, Bertolotti R, Langlois P, Gentilini M (1987) Plasmodium ovale: in vitro development of hepatic stages. Exp Parasitol 64:393–400
Mehlhorn H, Markus MB (1976) Electron microscopy of stages of Isospora felis of the cat in the mesenteric lymphnode of the mouse. Z Parasitenkd 51:15–24
Mejia GA, Alvarez CA, Pulido HH, Ramírez B, Cardozo C, Suárez Y, Lobelo R, Sarquis T, Uribe AM (2006) Malaria in a liver transplant recipient: a case report. Transplant Proc 38:3132–3134
Minodier P, Lanza-Silhol F, Piarroux R, Garnier JM, Dumon H, Unal D (1999) Imported pediatric malaria in Marseille. Arch Pediatr 69:935–943
Monge-Maillo B, Norman F, Pérez-Molina JA, Díaz-Menéndez M, Rubio JM, López-Vélez R (2012) Plasmodium falciparum in asymptomatic immigrants from sub-Saharan Africa, Spain. Emerg Infect Dis 18:356–357
Moran E, Collins L, Clayton S, Peto T, Bowler IC (2004) Case of cryptic malaria. Commun Dis Publ Hlth 7:142–144
Morgan GS, Chiodini P, Evans M (2012) Relapsing malaria: two cases of malaria presenting 8 months after return from Africa. Br J Gen Pract 62:555–556
Morovic M, Poljak I, Miletic B, Troselj-Vukic B, Seili-Bekafigo I, Milotic I (2003) Late symptomatic Plasmodium malariae relapse in the territory of the former Yugoslavia. J Travel Med 10:301–302
Muehlenbachs A, Mutabingwa TK, Fried M, Duffy PE (2007) An unusual presentation of placental malaria: a single persisting nidus of sequestered parasites. Hum Pathol 38:520–523
Müller-Stöver I, Verweij JJ, Hoppenheit B, Göbels K, Häussinger D, Richter J (2008) Plasmodium malariae infection in spite of previous antimalarial medication. Parasitol Res 102:547–550
Nathwani D, Currie PF, Smith CC, Khaund R (1991) Recurrent Plasmodium ovale infection from Papua New Guinea—chloroquine resistance or inadequate primaquine therapy? J Infect 23:343–345
Nolder D, Oguike MC, Maxwell-Scott H, Niyazi HA, Smith V, Chiodini PL, Sutherland CJ (2013) An observational study of malaria in British travellers: Plasmodium ovale wallikeri and Plasmodium ovale curtisi differ significantly in the duration of latency BMJ Open 3. pii: e002711. doi: 10.1136/bmjopen-2013-002711
Nosten F (2010) Waking the sleeping beauty. J Infect Dis 202:1300–1301
Odolini S, Apostoli A, Casari S, Matteelli A, Castelli F (2014) Recrudescence of Plasmodium falciparum malaria in a primigravid woman with anaemia as the only sign of disease. J Obstet Gynaecol 34:356
Omonuwa S, Omonuva S (2002) Malaria recurrence caused by Plasmodium falciparum. J Am Board Fam Pract 15:159–160
Owusu-Ofori AK, Parry C, Bates I (2010) Transfusion-transmitted malaria in countries where malaria is endemic: a review of the literature from sub-Saharan Africa. Clin Infect Dis 51:1192–1998
Parez N, Delée S, Favier R, Adam M, Quinet B, Grimprel E, Bégué P (2002) [Imported malaria in children in, 1999. Study of the Armand-Trousseau Hospital in Paris]. Arch Pediatr 9:371–376
Patterson JE, Bia FJ, Miller K, McPhedran P (1987) Relapsing malaria infection acquired in Kenya. Yale J Biol Med 60:245–253
Popper KR (1935) Logik der Forschung Springer, Wien 1935; Herbert Keuth Edt., Mohr Siebeck Verlag, Tübingen, Germany 2005 (11th ed., online 2.ed.1966 with remarks). ISBN 3-16-146234-3
Pukrittayakamee S, Vanijanonta S, Chantra A, Clemens R, White NJ (1994) Blood stage antimalarial efficacy of primaquine in Plasmodium vivax malaria. J Infect Dis 169:932–935
Rai P, Majumdar K, Sharma S, Chauhan R, Chandra J (2015) Congenital malaria in a neonate: case report with a comprehensive review on differential diagnosis, treatment and prevention in Indian perspective. J Parasit Dis 39:345–348
Rajapakse S, Rodrigo C, Fernando SD (2015) Tafenoquine for preventing relapse in people with Plasmodium vivax malaria. Cochrane Database Syst Rev 4:CD010458. doi:10.1002/14651858.CD010458.pub2
Redmond P, O’Shea B, Crowe M (2012) ‘Not another UTI…’. Age Ageing 41:569–570
Richter J, Franken G, Mehlhorn H, Labisch A, Häussinger D (2010) What is the evidence for the existence of Plasmodium ovale hypnozoites? Parasitol Res 107:1285–1290
Rodger LM, Witwatersrand MB (1944) Malaria as a non-relapsing disease. A review of 1619 cases in Northern Rhodesia. Lancet: 533-534
Rojo-Marcos G, Cuadros-González J, Gete-García L, Gómez-Herruz P, López-Rubio M, Esteban-Gutierrez G (2011) Plasmodium ovale infection: description of 16 cases and a review]. [Article in Spanish. Enferm Infecc Microbiol Clin 29:204–208
Rombo L, Edwards G, Ward SA, Eriksson G, Lindquist L, Lindberg A, Runehagen A, Björkman A, Hylander NO (1987) Seven patients with relapses of Plasmodium vivax or Plasmodium ovale despite primaquine treatment. Trop Med Parasitol 38:49–50
Rubio JM, Jiménez Del Bianco AI, Cervera-Alonso Y, Fernandez-Garcia MD, Lanza M, Ta Tang TH, Sevil Puras F, Blanco L. (2015) Vivax malaria in a blood donor in Spain, relapse or a new infection in a malaria non-endemic country? Vox Sang. 2015 Oct 28. doi: 10.1111/vox.12352. [Epub ahead of print]
Sankar J, Menon R, Kottarathara AJ (2010) Congenital malaria—a case report from a non-endemic area. Trop Biomed 27:326–329
Schwartz E, Parise M, Kozarsky P, Cetron M (2003) Delayed onset of malaria—implications for chemoprophylaxis in travelers. N Engl J Med 349:1510–1516
Shortt HE, Garnham PCC (1948) Demonstration of a persisting exo-erythrocytic cycle in Plasmodium cynomolgi and its bearing on the production of relapses. Bull WHO 78:1447–1449
Shute PG (1946) Latency and long-term relapse in benign tertian malaria. Trans R Soc Trop Med Hyg 40:189–200
Shute PG, Lupascu G, Branzei P, Maryon M, Constantinescu P, Bruce-Chwatt LJ, Draper CC, Killick-Kendrick R, Garnham PC (1976) A strain of Plasmodium vivax characterized by prolonged incubation: the effect of numbers of sporozoites on the lenght of the prepatent period. Trans R Soc Trop Med Hyg 70(5/6):474–481
Siala E, Gastli M, Essid R, Jemal S, Ben Abdallah R, Ben Abda I, Aoun K, Bouratbine A (2015) Late relapse of imported Plasmodium ovale malaria: a case report. Tunis Med 93:347–349
Skoutelis SA, Vassalou E, Bassaris H (2000) Drug-induced acute malaria. Scand J Infect Dis 32:333
Sutherland CJ, Laundy M, Price N, Burke M, Fivelman QL, Pasvol G, Klein JL, Chiodini PL (2008) Mutations in the Plasmodium falciparum cytochrome b gene are associated with delayed parasite recrudescence in malaria patients treated with atovaquone-proguanil. Malar J 7:240
Sutherland CJ, Tanomsing N, Nolder D, Oguike M, Jennison C, Pukrittayakamee S, Dolecek C, Hien TT, do Rosário VE, Arez AP, Pinto J, Michon P, Escalante AA, Nosten F, Burke M, Lee R, Blaze M, Otto TD, Barnwell JW, Pain A, Williams J, White NJ, Day NP, Snounou G, Lockhart PJ, Chiodini PL, Imwong M, Polley SD (2010) Two nonrecombining sympatric forms of the human malaria parasite Plasmodium ovale occur globally. J Infect Dis 201:1544–1550
Szmitko PE, Kohn ML, Simor AE (2009) Plasmodium falciparum malaria occurring 8 years after leaving an endemic area. Diagnost Microbiol Infect Dis 63:105–107
Talabiska DG, Komar MJ, Wytock DH, Rubin RA (1996) Post-transfusion acquired malaria complicating orthotopic liver transplantation. Am J Gastroenterol 91:376–379
Taleb NN (2007) The Black Swan, the impact of the highly improbable. Random House; New York; U.S.A.
Teuscher F, Gatton ML, Chen N, Peters J, Kyle DE, Cheng Q (2010) Artemisinin-induced dormancy in Plasmodium falciparum: duration, recovery rates, and implications in treatment failure. J Infect Dis 202:1362–1368
Theunissen C, Janssens P, Demulder A, Nouboussié D, Van Esbroeck M, Gompel V, Van den Ende J (2009) Falciparum malaria in patient 9 years after leaving a malaria endemic area. Emerg Infect Dis 15:115–116
Trager W, Most H (1963) A long delayed primary attack of ovale malaria. Am J Trop Med Hyg 12:837–839
Ülçay A, Karaahmetoğlu G, Turhan V, Erdem H, Acar A, Öncül O, Görenek L (2014) The management of therapeutic failure in a falciparum malaria patient under oral arthemether-lumefantrine therapy. Turkiye Parazitol Derg 38:61–67
Vale N, Moreira R, Gomes P (2009) Primaquine revisited six decades after its discovery. Eur J Med Chem 44:937–953
Van den Ende J, van Gompel A, van den Enden E, Taelman H, Vanham G, Vervoort T (2000) Hyperreactive malaria in expatriates returning from sub-Saharan Africa. Trop Med Int Health 5:607–611
Van den Enden E, van Gompel A, van den Ende J, Vervoort T (1991) Late Plasmodium ovale malaria. Lancet 338:1339
Vandenbos F, Delaunay P, Del Giudice P, Counillon E (2006) Relapse of Plasmodium falciparum malaria in a patient treated with artesunate. Med Mal Infect 36:288–289
Vinetz JM, Li J, McCutchan TF, Kaslow DC (1998) Plasmodium malariae infection in an asymptomatic 74-year-old Greek woman with splenomegaly. N Engl J Med 338:367–371
Voza T, Miller JL, Kappe SH, Sinnis P (2012) Extrahepatic exoerythrocytic forms of rodent malaria parasites at the site of inoculation: clearance after immunization, susceptibility to primaquine, and contribution to blood-stage infection. Infect Immun 80:2158–2164
White NJ (2011) Determinants of relapse periodicity in Plasmodium vivax malaria. Malar J 10:297
White NJ (2014) Malaria. Manson’s tropical diseases, 23rd edition 2014; Farrar J, Hotez P, Junghanss T, Kang G, Lalloo D, White, NJ eds. Saunders. Pp: 532-605.
White NJ, Imwong M (2012) Relapse. Adv Parasitol 80:113–150
Zhu L, Mok S, Imwong M, Jaidee A, Russell B, Nosten F, Day NP, White NJ, Preiser PR, Bozdech Z (2016) New insights into the Plasmodium vivax transcriptome using RNA-Seq. Sci Rep 6:20498. doi:10.1038/srep20498
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Richter, J., Franken, G., Holtfreter, M.C. et al. Clinical implications of a gradual dormancy concept in malaria. Parasitol Res 115, 2139–2148 (2016). https://doi.org/10.1007/s00436-016-5043-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00436-016-5043-0